To the Editor: The article by Williams and colleagues1 is a narrative review of prostate cancer care from a urological perspective. However, developing recommendations for prostate cancer screening requires complementary perspectives, including population health, general practice, and the wider community.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- 1. Williams ISC, McVey A, Perera S, et al. Modern paradigms for prostate cancer detection and management. Med J Aust 2022; 217: 424‐433. https://www.mja.com.au/journal/2022/217/8/modern‐paradigms‐prostate‐cancer‐detection‐and‐management
- 2. Ilic D, Djulbegovic M, Jung JH, et al. Prostate cancer screening with prostate‐specific antigen (PSA) test: a systematic review and meta‐analysis. BMJ 2018; 362: k3519.
- 3. Royal Australian College of General Practitioners. Prostate cancer. In: Guidelines for preventive activities in general practice; 9th ed. Melbourne: RACGP, 2018. https://www.racgp.org.au/clinical‐resources/clinical‐guidelines/key‐racgp‐guidelines/view‐all‐racgp‐guidelines/guidelines‐for‐preventive‐activities‐in‐general‐pr/early‐detection‐of‐cancers/prostrate‐cancer (viewed Feb 2023).
- 4. National Health and Medical Research Council. PSA testing for prostate cancer in asymptomatic men — information for health practitioners. Canberra: NHMRC, 2014. https://www.nhmrc.gov.au/sites/default/files/documents/reports/clinical%20guidelines/men4d‐psa‐testing‐asymptomatic.pdf (viewed Feb 2023).
- 5. Jahn JL, Giovanni EL, Stampfer MJ. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the prostate‐specific antigen‐era. Int J Cancer 2015; 137: 2795‐2802.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.